GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.356 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, TERT, XDH |
10.6677 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6677 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, FLT3, GPER1, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
10.6677 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, FLT3, GPER1, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
10.6677 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ABCG2, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TERT, TYR |
10.6677 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, INSR, KIT, MMP2, PPARA, SMAD3, SRC, TEK |
10.6677 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
10.1786 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SRC, TEK, TYR |
9.96185 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.40755 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
9.04008 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MET, MIF, PPARA, SMAD3, SRC, TEK, TERT, XDH |
8.99317 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
8.8878 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HSPA1A, MIF, PIM1, PPARA, TYR, XDH |
8.75771 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
8.75748 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
8.71283 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.67837 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, KIT, PPARA, SRC, TEK |
8.48222 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP2, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
8.44938 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, SRC, TEK, XDH |
8.2751 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.18958 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, KIT, MET, MIF, PPARA |
8.18301 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
8.1485 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
8.1485 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.1485 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
8.13408 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
8.03995 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, SMAD3, SRC, TERT |
8.00322 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, FLT3, GPER1, SRC, TEK, TYR |
7.91983 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.90552 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
7.89354 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, SMAD3, SRC, TEK, TERT, XDH |
7.87249 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH |
7.84475 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT |
7.72887 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F10, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.72887 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, KIT, PPARA, SMAD3, SRC, TEK, TYR |
7.64498 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
7.61222 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
7.57795 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, EGFR, F10, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, SRC, TEK, XDH |
7.56567 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT |
7.41412 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.29522 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.22886 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, SRC, TYR |
7.16931 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, MMP9, SRC, TERT |
7.11965 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
6.76302 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MMP2, SMAD3, SRC |
6.71504 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, FABP4, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, SMAD3, SRC, TEK, TERT, XDH |
6.71504 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CSNK2A1, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, TEK, TERT |
6.66005 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GPER1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TERT, TYR |
6.65675 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HCAR2, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH |
6.54805 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
6.35059 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
6.33169 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, SMAD3, SRC, TERT |
6.18874 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1, HSD17B2 |
6.1345 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
6.11805 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, MIF, PIM1, SRC, TEK, TYR |
6.1032 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
6.09991 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CYP19A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, XDH |
5.97035 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, INSR, MET, SMAD3, SRC, TERT |
5.94126 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, F10, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
5.80454 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
5.79279 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, GPER1, HSD17B2, IGF1R, INSR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
5.77975 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, GPER1, INSR, KIT, MET, SRC, TEK, XDH |
5.69816 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.55868 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.45183 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.4371 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
5.38939 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, EGFR, GPER1, HCAR2, INSR, MIF, MMP12, SMAD3, SRC, TERT |
5.38858 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.3842 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR |
5.35612 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
5.35612 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
5.29441 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, DRD1, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, KIT, MIF, MMP9, SMAD3, SRC, TEK, XDH |
5.29441 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, DRD1, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, KIT, MIF, MMP9, SMAD3, SRC, TEK, XDH |
5.29441 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, XDH |
5.19635 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, EGFR, HSPA1A, KIT, MMP2, PPARA, SMAD3, SRC, TEK, TERT, TYR |
5.17332 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
5.12435 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, GPER1, HCAR2, HSPA1A, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TERT |
5.10894 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DNMT1, DRD1, EGFR, ESR1, FLT3, GPER1, IGF1R, INSR, KIT, MMP2, SMAD3, SRC |
5.08989 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CSNK2A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KIT, MET, MIF, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
4.99545 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, DNMT1, ESR1, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.91297 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, FLT3, GPER1, INSR, KDR, KIT, MIF, SRC, TEK, XDH |
4.8849 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, XDH |
4.84548 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, SRC, TEK, XDH |
4.82662 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, GPER1, GPR35, INSR, MET, SMAD3 |
4.8183 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, XDH |
4.80796 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF |
4.76853 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, GPER1, SRC |
4.75631 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, SRC, TEK, XDH |
4.72113 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, KIT, MET, MIF, PPARA |
4.70701 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TERT, XDH |
4.6713 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, KIT, MET, SRC, TEK |
4.65949 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, DRD1, DUSP3, EGFR, ESRRB, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP9, PPARA, SRC, TEK, XDH |
4.6235 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.61092 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DNMT1, DRD1, EGFR, ESR1, GPER1, IGF1R, INSR, MMP2, MMP9, SRC |
4.5967 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF |
4.5926 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
4.57447 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.55561 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
4.5316 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KIT, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, TERT, XDH |
4.5203 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.49721 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.44075 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, EGFR, GPER1, KIT |
4.44075 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, EGFR, GPER1, KIT |
4.44075 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, EGFR, GPER1, HCAR2, KDR, MIF, SRC |
4.41617 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
4.41617 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, EGFR, GPER1, GPR35, HCAR2, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT |
4.41365 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.40659 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.40102 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TERT, XDH |
4.37862 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AR, AURKB, BCL2, EGFR, ESR1, ESR2, FLT3, GPER1, HSPA1A, INSR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT, XDH |
4.26465 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MMP9, TERT |
4.24634 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DUSP3, DYRK1A, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, SMAD3, SRC, TERT, XDH |
4.24155 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SRC, TEK |
4.22172 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, EGFR, GPER1 |
4.21697 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, FABP3, FLT3, GPER1, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.19857 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KDR, KIT, MIF, MMP9, SMAD3, SRC, TEK, XDH |
4.18103 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
4.15284 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HCAR2, HSD17B1, HSD17B2 |
4.14797 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.11408 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, DYRK1A, ESR1, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, SRC, XDH |
4.08488 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
4.06401 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
4.06171 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
4.06111 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, DRD1, DUSP3, EGFR, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP9, SRC, TEK, XDH |
3.99548 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, DNMT1, DYRK1A, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KDR, KIT, MIF, MMP9, SMAD3, SRC, TEK, XDH |
3.96447 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.96447 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.9641 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, ESRRB, FLT3, GPER1, INSR, KDR, KIT, MIF, MMP9, SRC, TEK, XDH |
3.95558 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
3.93202 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.89641 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TYR, XDH |
3.83015 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.83015 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, GPER1, HCAR2, KIT, PPARA, SRC, TEK |
3.819 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.79335 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, GPER1, KDR, SRC |
3.79032 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, KIT, PPARA, SRC |
3.77297 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.76466 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, GPER1, GPR35, SMAD3 |
3.76466 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, EGFR, ESR1, FABP4, GPER1, KDR, MET, MIF, MMP12, PPARA, SMAD3, TEK |
3.76259 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DUSP3, EGFR, GPER1, INSR, MIF, SRC, TERT |
3.75103 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.73612 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
3.72725 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.71362 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.70748 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66008 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66008 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, GPER1, SRC |
3.65593 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA |
3.65593 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, GPER1, KDR, KIT, TEK |
3.65311 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.64728 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.6443 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF |
3.61837 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9, TERT |
3.57913 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.56736 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, BCL2, DNMT1, DYRK1A, EGFR, FLT3, GPER1, INSR, KDR, KIT, MIF, MMP9, SRC, TEK, XDH |
3.56723 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, FLT3, GPER1, INSR, KDR, KIT, MIF, MMP9, SRC, TEK, XDH |
3.55745 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, GPER1, IGF1R, INSR, MMP2, SRC |
3.55324 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, MMP2, MMP9, SRC |
3.53948 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, SRC |
3.52836 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DNMT1, GPER1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.41308 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.41155 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.40787 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ABCG2, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, EGFR, FABP3, KDR, SRC |
3.37631 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
3.37631 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, GPER1, MMP12, PPARA, SMAD3, TEK |
3.36544 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.3218 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DNMT1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT |
3.29613 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.29613 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.29279 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.29279 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD1, EGFR, HSPA1A |
3.29279 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, GPER1, PPARA, SMAD3, TEK |
3.28409 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, EGFR, GPER1, IGF1R, INSR, MMP2, SRC |
3.28409 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, KIT, TEK |
3.27331 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, APP, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, GPER1, GPR35, SMAD3 |
3.26088 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
3.26088 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, GPER1, HCAR2, MIF, MMP12, SRC |
3.23966 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, MIF, SRC |
3.23966 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.21888 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.21888 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT |
3.21888 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.21888 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21888 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
3.19638 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GPER1, IGF1R, INSR, PPARA, SRC, TEK |
3.16355 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.15638 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.15638 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC, TEK |
3.14853 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.12069 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
3.11889 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.11889 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.10755 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.10755 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.07826 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, SRC |
3.07826 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9, TERT |
3.0705 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, GPER1, KDR, MIF, SRC, TEK |
3.05967 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TERT |
3.04398 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, GPER1, KDR, MIF, SRC, TEK |
3.04211 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
3.03007 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DNMT1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
3.02812 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, GPER1, MIF, PPARA, SMAD3, TEK |
3.01132 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.98158 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CYP1B1, FABP3, GPER1, HSPA1A, SMAD3, TERT, XDH |
2.93308 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DUSP3, ESR1, ESRRA, GPER1, HCAR2, HSPA1A, KIT, MIF, MMP12, MMP2, SMAD3, SRC |
2.93308 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.9196 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, GPER1, HSPA1A, MIF, MMP9, SMAD3, SRC, TERT |
2.91555 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
2.91497 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, GPER1, HCAR2, MIF, MMP12, SRC |
2.91197 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.91197 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, MIF |
2.89942 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.89942 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, SRC, TERT |
2.88376 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.86911 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, PPARA, SMAD3, TEK |
2.86911 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
2.83976 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, GPER1, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT |
2.82283 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.82283 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, DRD1, GPER1, GPR35, MIF, MMP9 |
2.81969 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.81202 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, EGFR, ESR1, FLT3, GPER1, HSPA1A, INSR, KIT, MIF, SMAD3, SRC, TEK, TERT, XDH |
2.7875 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.77438 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.7709 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, KDR, SRC |
2.76176 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, EGFR, GPER1, HCAR2 |
2.71218 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, GPER1, HSPA1A, KIT, MIF, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TERT |
2.71213 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, EGFR, GPER1, HCAR2, MIF, MMP12, SMAD3, SRC |
2.70586 |
[BP] GO:0055080 |
cation homeostasis
|
ABCG2, APP, BCL2, CA2, CA7, DRD1, EGFR, ESR1, GPER1, GPR35, SMAD3 |
2.70586 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, GPER1, INSR, KDR, KIT, MIF, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.70272 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, TYR |
2.6722 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, GPER1, SRC |
2.6707 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, EGFR, GPER1, SRC, TEK |
2.6707 |
[BP] GO:2001236 |
regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, GPER1, HSPA1A, SRC, TERT |
2.6707 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, KIT, MIF, SRC |
2.66705 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.66705 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.66705 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, KDR, MIF, MMP12, PPARA, SMAD3, SRC, TERT, XDH |
2.65838 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT |
2.65838 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, EGFR, FUT7, KDR, KIT, MET, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.65511 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CSNK2A1, CYP1A1, DUSP3, EGFR, GPER1, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TERT |
2.65073 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
2.65073 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.63974 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, SRC |
2.63852 |
[BP] GO:0050714 |
None
|
ACHE, EGFR, GPER1, HCAR2, MIF, MMP12, SRC |
2.63188 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.61066 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, TERT, XDH |
2.60187 |
[BP] GO:0051172 |
None
|
APP, AR, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
2.58776 |
[BP] GO:2000351 |
None
|
GPER1, KDR, TEK, TERT |
2.58214 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CSNK2A1, DNMT1, EGFR, ESR1, ESR2, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.56216 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.56216 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT |
2.55004 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.54676 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.54676 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, SMAD3, SRC, TEK |
2.5376 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, SRC, TEK |
2.5376 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TERT |
2.53561 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.53561 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.53561 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.53561 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.53561 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53311 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53311 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, TEK, TYR |
2.53282 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.52178 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, DNMT1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, KIT, MET, MMP12, PPARA, SMAD3, SRC, TERT |
2.52178 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, EGFR, ESR1, KIT, SRC |
2.52076 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, SMAD3, SRC, TEK |
2.51871 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.51204 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.51204 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.51204 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CYP1A1, DRD1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, KDR, KIT, MET, MIF, MMP2, MMP9, SMAD3, SRC, TEK, TERT |
2.51204 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.51204 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, SRC, TERT |
2.51204 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
2.50133 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
2.50133 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, EGFR, ESR1, FLT3, GPER1, INSR, KIT, SRC |
2.49603 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.49288 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DNMT1, DRD1, EGFR, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, NUAK1, SRC, TEK |
2.47806 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, KDR, MIF, MMP12, MMP9, PPARA, SMAD3, SRC, TERT, XDH |
2.471 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.46389 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.46389 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, EGFR, GPER1, INSR, SMAD3 |
2.46323 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.45191 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, GPER1, KDR, KIT, TEK, TERT |
2.45191 |
[BP] GO:0035295 |
tube development
|
AKR1B1, AR, CYP1A1, EGFR, KIT, SMAD3 |
2.45191 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ABCG2, APP, BCL2, CA2, CA7, DRD1, ESR1, GPER1, GPR35, SMAD3 |
2.43959 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.43888 |
[BP] GO:0008406 |
gonad development
|
BCL2, CYP19A1, ESR1, INSR, KIT |
2.43888 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, SRC |
2.41833 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, GPER1, HCAR2, MIF, MMP12, SRC |
2.40398 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.39341 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, SMAD3, SRC |
2.39341 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.38841 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, KIT, MIF, SRC |
2.38568 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.38562 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ABCG2, APP, BCL2, CA2, CA7, DRD1, ESR1, GPER1, GPR35, SMAD3 |
2.36844 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESR1, ESRRA, GPER1, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT, XDH |
2.35398 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.33288 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.33092 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.33092 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.3005 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3005 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA |
2.29855 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, MIF, SRC, TEK |
2.29762 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.29762 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CSNK2A1, CYP1A1, EGFR, GPER1, HSPA1A, INSR, MIF, TERT |
2.29762 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, GPER1, HCAR2, MIF, MMP12, SMAD3, SRC |
2.2905 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.28877 |
[BP] GO:0051234 |
None
|
ABCB1, ABCG2, ACHE, ADORA1, ALOX5, APP, AR, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, EGFR, F10, FABP3, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, SRC, TERT, XDH |
2.26811 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.26089 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
2.24544 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.24206 |
[BP] GO:0051179 |
None
|
ABCB1, ABCG2, ACHE, ADORA1, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, EGFR, ESR1, F10, FABP3, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, SRC, TERT, XDH |
2.24206 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.24206 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24206 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, EGFR, KIT, TYR |
2.21849 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20716 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1 |
2.2041 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, MIF, SRC, TEK |
2.1928 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.19202 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.19202 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.16697 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, MIF, SRC |
2.16557 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MET, MMP12, PPARA, SMAD3, SRC, TERT |
2.15561 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.15093 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CSNK2A1, EGFR, GPER1, HCAR2, MIF, MMP12, SMAD3, SRC, TERT |
2.14754 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.14343 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, EGFR, GPER1, SRC, TEK |
2.14343 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.13892 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, GPER1, MMP9, SMAD3, SRC, XDH |
2.13613 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, SMAD3, SRC, TERT |
2.12792 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.12572 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.12572 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, DRD1, GPER1, GPR35, KDR, SRC |
2.12551 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, IGF1R, INSR, SRC |
2.12055 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, EGFR, MET, SRC, TEK |
2.12015 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.10563 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF |
2.07076 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, SRC |
2.06856 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.04857 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.04854 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.04788 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3 |
2.04788 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04788 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SMAD3, SRC, TEK |
2.04481 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SMAD3, SRC, TEK |
2.04481 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.04279 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.02891 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ABCG2, APP, BCL2, CA2, CA7, DRD1, ESR1, GPER1, GPR35, SMAD3 |
2.02891 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD1, EGFR, ESR1, GPER1, GPR35, SMAD3 |
2.01631 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, MIF, SRC |
2.00392 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.00003 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, EGFR, ESR1, F10, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, SMAD3, SRC, TEK, TERT |
3.35832 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SHBG, SMAD3, SRC, TERT, TYR, XDH |
3.21888 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, MET, MIF, TEK |
2.55248 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ABCG2, ADORA1, ADORA3, APP, AXL, BACE1, CA2, CA4, CA9, DRD1, DUSP3, EGFR, F10, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
2.4868 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.33065 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ABCG2, ADORA1, CA2, CA4, CA9, DRD1, EGFR, GPER1, INSR, MET, SRC, TEK |
2.32279 |
[CC] GO:0043226 |
organelle
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SHBG, SMAD3, SRC, TERT, TYR, XDH |
2.29714 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, EGFR, F10, FLT3, GPER1, HSD17B2 |
2.26089 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, BACE1, CA4, DRD1, F10, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.19834 |
[CC] GO:0045121 |
membrane raft
|
APP, BACE1, EGFR, INSR, KDR, SRC, TEK |
2.15561 |
[CC] GO:0098857 |
membrane microdomain
|
APP, BACE1, EGFR, INSR, KDR, SRC, TEK |
2.14301 |
[CC] GO:0016020 |
membrane
|
ABCB1, ABCG2, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, EGFR, ESR1, F10, FLT3, FUT7, GPER1, GPR35, HCAR2, HSD17B2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, SMAD3, SRC, TEK, TERT, TYR |
2.03067 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, GPER1, INSR, SRC |
2.00059 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TYR, XDH |
17.2177 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.9341 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ABCG2, ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, TYR, XDH |
12.7487 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DUSP3, DYRK1A, EGFR, F10, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK, TERT, TYR, XDH |
11.0835 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6677 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.4469 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
8.75566 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.75566 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.9783 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, TERT, TYR, XDH |
7.53594 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
7.41412 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SRC, TEK |
6.76405 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.69436 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, TERT, TYR, XDH |
6.63977 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.63977 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.63977 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, INSR, SHBG |
6.41058 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, SHBG |
6.37593 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.20351 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.11617 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.57696 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.29833 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.28826 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.26159 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
5.2192 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.81961 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
4.44075 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.41617 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, SMAD3, TEK |
4.40102 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
4.24634 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, AOX1, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP9, SMAD3, TERT, TYR, XDH |
4.15305 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.11408 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.07712 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
4.07684 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.00058 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.97676 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.89408 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT |
3.8405 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, GPER1, HSD17B1, PPARA, SHBG |
3.72667 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ABCG2, ADORA1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.63987 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.61837 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ABCG2, ADORA1, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, SHBG, SMAD3, SRC, TEK, TERT, XDH |
3.40378 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
3.35832 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, ABCG2, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.14853 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, ABCG2, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.14853 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.11795 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.11795 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.09334 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.00251 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.9668 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
2.93716 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.9196 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.9196 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, SRC, XDH |
2.91197 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ABCG2, AOX1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.90251 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.73384 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, BACE1, CSNK2A1, DUSP3, DYRK1A, EGFR, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK |
2.50239 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BACE1, BCL2, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, KIT, MET, MIF, PPARA, SMAD3, SRC, TEK |
2.50239 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.43888 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.43888 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, EGFR, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
2.38323 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, EGFR, FLT3, GPER1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
2.38323 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ABCG2, ADORA1, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.36808 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, SMAD3, SRC, TERT |
2.32255 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.3005 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.3005 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.3005 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.25138 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, SMAD3 |
2.23412 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.16069 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ABCG2, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.1392 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.12792 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.12572 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.05493 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.03568 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.03067 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, ABCG2, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.02508 |